Leading artificial intelligence (AI)-based medical imaging companies Viz.ai and Avicenna.AI have announced the integration of Avicenna.AI’s CINA-iPE and CINA-ASPECTS tools into Viz.ai’s One platform. A press release states that the combination of Avicenna.AI’s two AI-based algorithms alongside Viz.ai’s care coordination capabilities will provide radiologists and other specialists with additional insights from computed tomography (CT) scans to advance fast and accurate decision-making, driving better patient care.
“This expanded partnership with Avicenna.AI represents an important step forward in our mission to improve patient care through AI-powered, clinical workflows,” said Justin Ryea, director of product at Viz.ai. “By integrating CINA-iPE and CINA-ASPECTS into Viz.ai One, we are providing clinicians with an even more robust, all-in-one neurovascular solution that they can trust. This can help speed up the decision-making process and ensure that patients receive appropriate treatment as quickly as possible.”
The CINA-ASPECTS tool automatically assesses Alberta stroke programme early CT scores (ASPECTS) from CT brain images, providing an objective and reliable measure of stroke severity. The CINA-iPE tool detects incidental pulmonary embolism (PE) during routine CT scans, and is intended to address delayed and missed findings. Avicenna.AI received 510(k) clearance from the US Food and Drug Administration (FDA) for its CINA-iPE and CINA-ASPECTS tools in March 2024.
“We are thrilled to further our partnership with Viz.ai,” said Cyril Di Grandi, chief executive officer (CEO) of Avicenna.AI. “Incorporating CINA-iPE and CINA-ASPECTS into Viz.ai’s platform will allow us to bring a higher level of quality and efficiency to patient care. Our shared goal of empowering healthcare professionals with innovative tools to make critical decisions quickly and confidently can improve outcomes for more patients by helping to diagnose life-threatening conditions faster, and facilitating appropriate follow-up care to patients when they need it.”
